Your search returned 7 results.

Results
	1.	Descriptive analysis of genetic aberrations and cell of origin in Richter transformation. MedStar authors: Chitalia, Ami PMID: 30632835 Year: 2019 Citation: Leukemia & Lymphoma. 60(4):971-979, 2019 04. Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Cheson BD, Chitalia A, Khan N, McCutcheon JN, Ozdemirli M, Swoboda DM DOI: https://dx.doi.org/10.1080/10428194.2018.1516878 Add to cart (remove)
	2.	Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer?. MedStar authors: Alintah, Princess Chitalia, Ami Dilawari, Asma Gallagher, Christopher Tiwari, Shruti PMID: 33512741 Year: 2021 Citation: Oncologist. 26(4):292-e548, 2021 04. Institution: MedStar Health Research Institute Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Adams-Campbell L, Alintah P, Chitalia A, Dash C, Dilawari A, Gallagher C, Paxman R, Tiwari S DOI: https://dx.doi.org/10.1002/onco.13690 Add to cart (remove)
	3.	Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer. MedStar authors: Blackburn, Matthew J Chitalia, Ami Dilawari, Asma Gallagher, Christopher Lynce, Filipa Mohebtash, Mahsa Tiwari, Shruti R PMID: 34157782 Year: 2021 Citation: Cancer. 127(19):3622-3630, 2021 10 01. Institution: MedStar Franklin Square Cancer Center at Loch Raven Campus MedStar Washington Hospital Center Washington Cancer Institute Department: Hematology & Oncology Fellowship Hematology and Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Abu-Khalaf M, Blackburn MJ, Chitalia A, Dilawari A, Gallagher C, Hahn OM, Isaacs C, Lynce F, Mohebtash M, Pohlmann PR, Shajahan-Haq AN, Tan M, Tiwari SR, Warren R, Wu T, Zhuo R DOI: https://dx.doi.org/10.1002/cncr.33620 Add to cart (remove)
	4.	Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. MedStar authors: Chitalia, Ami Gallagher, Christopher Schlam, Ilana Swain, Sandra M Tiwari, Shruti PMID: 38105958 Year: 2023 Citation: MedRxiv : the Preprint Server for Health Sciences. 2023 Dec 04 Institution: Washington Cancer Institute Department: Associate Dean for Research Development MedStar Health Medline publication type: Preprint Form of publication: Journal Article All authors: Lynce F, Mainor C, Donahue RN, Geng X, Jones G, Schlam I, Wang H, Toney NJ, Jochems C, Schlom J, Zeck J, Gallagher C, Nanda R, Graham D, Stringer-Reasor EM, Denduluri N, Collins J, Chitalia A, Tiwari S, Nunes R, Kaltman R, Khoury K, Gatti-Mays M, Tarantino P, Tolaney SM, Swain SM, Pohlmann P, Parsons HA, Isaacs C DOI: https://dx.doi.org/10.1101/2023.12.04.23297559 Add to cart (remove)
	5.	Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. MedStar authors: Chitalia, Ami Gallagher, Christopher Schlam, Ilana Swain, Sandra M Tiwari, Shruti PMID: 38538574 Year: 2024 Citation: Nature communications . 15(1):2691, 2024 Mar 27. Institution: Washington Cancer Institute Department: Associate Dean for Research Development MedStar Health Medline publication type: Clinical Trial, Phase II Journal Article Randomized Controlled Trial Form of publication: Journal Article All authors: Lynce F, Mainor C, Donahue RN, Geng X, Jones G, Schlam I, Wang H, Toney NJ, Jochems C, Schlom J, Zeck J, Gallagher C, Nanda R, Graham D, Stringer-Reasor EM, Denduluri N, Collins J, Chitalia A, Tiwari S, Nunes R, Kaltman R, Khoury K, Gatti-Mays M, Tarantino P, Tolaney SM, Swain SM, Pohlmann P, Parsons HA, Isaacs C DOI: https://dx.doi.org/10.1038/s41467-024-46961-x Add to cart (remove)
	6.	ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer. MedStar authors: Chitalia, Ami PMID: 38828938 Year: 2024 Citation: Journal of Clinical Oncology. :JCO2400526, 2024 Jun 03 Institution: MedStar Washington Hospital Center Department: Hematology/Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Schneider BP, Zhao F, Ballinger TJ, Garcia SF, Shen F, Virani S, Cella D, Bales C, Jiang G, Hayes L, Miller N, Srinivasiah J, Stringer-Reasor EM, Chitalia A, Davis AA, Makower DF, Incorvati J, Simon MA, Mitchell EP, DeMichele A, Miller KD, Sparano JA, Wagner LI, Wolff AC DOI: https://dx.doi.org/10.1200/JCO.24.00526 Add to cart (remove)
	7.	Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. MedStar authors: Chitalia, Ami Gallagher, Christopher Schlam, Ilana Swain, Sandra M PMID: 38730268 Year: 2024 Citation: Nature communications . 15(1):3957, 2024 May 10. Institution: MedStar Washington Hospital Center Department: Associate Dean for Research Development Hematology/Oncology MedStar Health Medline publication type: Published Erratum Form of publication: Journal Article All authors: Lynce F, Mainor C, Donahue RN, Geng X, Jones G, Schlam I, Wang H, Toney NJ, Jochems C, Schlom J, Zeck J, Gallagher C, Nanda R, Graham D, Stringer-Reasor EM, Denduluri N, Collins J, Chitalia A, Tiwari S, Nunes R, Kaltman R, Khoury K, Gatti-Mays M, Tarantino P, Tolaney SM, Swain SM, Pohlmann P, Parsons HA, Isaacs C DOI: https://dx.doi.org/10.1038/s41467-024-48359-1 Add to cart (remove)

Powered by Koha